Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Skraban–Deardorff é uma doença genética ultrarrara causada por variantes patogênicas do gene WDR26. É caracterizada por atraso global do desenvolvimento, deficiência intelectual, comportamento amigável, marcha incomum, convulsões, dificuldades de alimentação e características faciais distintas. A condição ocorre devido a níveis insuficientes da proteína WDR26 funcional, que interrompem vários mecanismos celulares envolvidos no desenvolvimento do sistema nervoso. Embora os casos relatados na literatura médica tenham ocorrido espontaneamente, ela pode ser herdada de forma autossômica dominante.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
15
pacientes catalogados
Início
Infancy
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, RS, ES, RJ +5CID-10: Q87.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
17 sintomas
😀
Face
15 sintomas
📏
Crescimento
7 sintomas
🦴
Ossos e articulações
6 sintomas
👁️
Olhos
6 sintomas
❤️
Coração
3 sintomas

+ 34 sintomas em outras categorias

Características mais comuns

100%prev.
Vermelhão do lábio inferior espesso
Obrigatório (100%)
100%prev.
Atraso global do desenvolvimento
Frequência: 15/15
100%prev.
Deficiência intelectual
Muito frequente (99-80%)
91%prev.
Comportamento alegre
Frequência: 10/11
90%prev.
Convulsão
Muito frequente (99-80%)
90%prev.
Vermelhão do lábio superior evertido
Muito frequente (99-80%)
95sintomas
Muito frequente (12)
Frequente (35)
Ocasional (43)
Muito raro (2)
Sem dados (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 95 características clínicas mais associadas, ordenadas por frequência.

Vermelhão do lábio inferior espessoThick lower lip vermilion
Obrigatório (100%)100%
Atraso global do desenvolvimentoGlobal developmental delay
Frequência: 15/15100%
Deficiência intelectualIntellectual disability
Muito frequente (99-80%)100%
Comportamento alegreHappy demeanor
Frequência: 10/1191%
ConvulsãoSeizure
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1
Últimos 10 anos200publicações
Pico2026116 papers
Linha do tempo
2025Hoje · 2026🧪 2010Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

WDR26WD repeat-containing protein 26Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

G-beta-like protein involved in cell signal transduction (PubMed:15378603, PubMed:19446606, PubMed:22065575, PubMed:23625927, PubMed:26895380, PubMed:27098453). Acts as a negative regulator in MAPK signaling pathway (PubMed:15378603). Functions as a scaffolding protein to promote G beta:gamma-mediated PLCB2 plasma membrane translocation and subsequent activation in leukocytes (PubMed:22065575, PubMed:23625927). Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accep

LOCALIZAÇÃO

CytoplasmNucleusMitochondrion

VIAS BIOLÓGICAS (1)
Regulation of pyruvate metabolism
MECANISMO DE DOENÇA

Skraban-Deardorff syndrome

An autosomal dominant syndrome characterized by psychomotor developmental delay, intellectual disability with delayed speech, febrile and non-febrile seizures, abnormal gait, and facial dysmorphism. Facial features include a prominent maxilla and upper lip that readily reveal the upper gingiva, widely spaced teeth, and a broad nasal tip.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
70.6 TPM
Pulmão
63.9 TPM
Skin Not Sun Exposed Suprapubic
61.8 TPM
Esôfago - Mucosa
60.3 TPM
Cervix Ectocervix
59.6 TPM
OUTRAS DOENÇAS (1)
Skraban-Deardorff syndrome
HGNC:21208UniProt:Q9H7D7

Variantes genéticas (ClinVar)

158 variantes patogênicas registradas no ClinVar.

🧬 WDR26: NM_001379403.1(WDR26):c.1865+3A>G ()
🧬 WDR26: NM_001379403.1(WDR26):c.1693G>A (p.Gly565Ser) ()
🧬 WDR26: NM_001379403.1(WDR26):c.391G>T (p.Glu131Ter) ()
🧬 WDR26: NM_001379403.1(WDR26):c.1309G>A (p.Val437Ile) ()
🧬 WDR26: GRCh37/hg19 1q21.1-44(chr1:143932350-249224684)x3 ()
Ver todas no ClinVar

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial

Centros para Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
0 papers (10 anos)
#1

Biallelic SUPT4H1 Variants Cause a Multisystem Neurodevelopmental Disorder Associated with Disrupted Transcription.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 14

We aimed to define the clinical and genetic basis of an autosomal recessive neurodevelopmental disorder identified in three unrelated families with an overlapping multisystem phenotype. Exome or genome sequencing was performed in six affected individuals from three families, revealing biallelic variants in SUPT4H1. Functional effects were evaluated using CRISPR and RNAi knockdown in C. elegans. Transcriptomic and proteomic profiling were conducted on patient-derived fibroblasts. Phylogenetic profiling assessed evolutionary conservation and co-evolution. Dopamine response was evaluated in two affected siblings. All individuals carried biallelic SUPT4H1 variants-one frameshift and two missense variants. Shared features included intellectual disability, dystonia, speech impairment, craniofacial dysmorphism, skeletal anomalies, and enamel hypoplasia. Functional modeling in C. elegans confirmed pathogenicity through neuromotor deficits. Multi-omics analyses revealed dysregulation of developmental gene networks and the transcriptional machinery with disrupted RNA polymerase complexes and cell cycle regulators. Dopamine treatment improved motor symptoms and normalized cerebrospinal neurotransmitter levels in two siblings. Biallelic variants in SUPT4H1 cause a previously unrecognized multisystem neurodevelopmental disorder. These findings underscore the importance of disrupted transcription in human disease and demonstrate how integrated multi-omics and cross-species modeling can reveal underlying mechanisms and provide a foundation for future studies of transcriptional regulation.

#2

Multisystem manifestations of Sjögren-Larsson syndrome in early childhood and its dental implications.

BMJ case reports2026 Mar 13

Sjögren-Larsson syndrome (SLS) constitutes a rare genetic disorder manifesting as a complex neurocutaneous condition characterised by congenital ichthyosis, progressive neurological impairment and intellectual disability. This case report presents an early childhood female patient exhibiting the classic triad of symptoms, along with significant oral complications, including severe dental caries, enamel demineralisation and gingivitis. Molecular genetic testing confirmed a homozygous pathogenic variant in the ALDH3A2 (Aldehyde Dehydrogenase 3 family member 2) gene, establishing the diagnosis. The patient's management encompassed a comprehensive multidisciplinary approach, integrating dental interventions under general anaesthesia, systemic therapies for spasticity and cutaneous manifestations, and regular follow-up care. This case highlights the critical importance of recognising oral manifestations in SLS and emphasises the need for integrated oral healthcare within the broader therapeutic framework for affected individuals.

#3

Tuberous sclerosis complex.

Nature reviews. Disease primers2026 Mar 12

Tuberous sclerosis complex (TSC) is a rare genetic disease caused by heterozygous loss-of-function variants in TSC1 or TSC2. Patients present with benign tumours known as hamartomas in the brain, eyes, lungs, kidneys, heart and skin. Many hamartomas contain mosaic second hit variants in TSC1 or TSC2. The most disabling features of TSC include epilepsy and TSC-associated neuropsychiatric disorders (TAND) such as intellectual disability and autism spectrum disorder. Remarkable progress has been made both in understanding the pathogenesis of TSC and in its clinical management, largely due to the discovery of the link between TSC1 and TSC2 and the mechanistic target of rapamycin (mTOR) signalling pathway. TSC1 and TSC2 form a protein complex that inhibits mTOR. Naturally occurring inhibitors of mTOR (rapamycin) and its analogues, collectively known as rapalogues, have been used to test various hypotheses in preclinical models and are approved for the treatment of several manifestations of TSC. Approved drug treatments (rapalogues) exist for subependymal giant cell astrocytomas, renal angiomyolipomas, pulmonary lymphangioleiomyomatosis, facial angiofibromas and refractory seizures. However, there is still an unmet need for effective treatment of TAND and refractory epilepsy, despite the available medical and surgical options.

#4

Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.

European journal of pediatrics2026 Mar 08

This study aims to expand the spectrum of Coffin-Siris syndrome (CSS), a rare and heterogeneous disorder, by thoroughly discussing its genetic, dysmorphic, and endocrine features through new cases and contributing to the literature. Eight patients who were referred to the genetics clinic with various complaints and subsequently diagnosed with CSS through microarray or clinical exome sequencing analyses were included in the study. The dysmorphic, genetic, and endocrine characteristics of eight genetically confirmed patients were evaluated. The patients, aged between 5 months and 6 years at the time of referral, comprised four females and four males. The most common reasons for referral were developmental delay and dysmorphic features. All patients exhibited varying degrees of dysmorphic facial features. Hypertrichosis, a typical feature of the syndrome, was present in five patients. Another characteristic finding was mild hypoplasia of the terminal fifth phalanges, observed in patients 1, 2, and 6. Consistent with this, mild/subtle hypoplasia and/or slight positional changes of the fifth fingernails were noted in these patients, rather than overt nail anomalies. In our study, eight variants were identified, two of which were novel. In our cohort, pathological short stature was observed in three patients, while hypothyroidism, transient hypercalcemia, cryptorchidism, and recurrent fractures were each identified in one patient. All three patients with short stature had delayed bone age with head circumference and BMI <  - 2 SDS. Seven patients were diagnosed with ARID1B-related CSS type 1, while one patient was diagnosed with SMARCA4-related CSS type 4. Among the eight findings across patients, two were deletion-type copy-number variations (CNVs) identified by microarray analysis, and six were sequence variants: two frameshift, two splice-site, one nonsense, and one synonymous. Seven variants were classified as pathogenic and one as likely pathogenic. Family studies confirmed that the variants were de novo and validated their clinical relevance.  CSS is a clinically and genetically heterogeneous syndrome. Patients may present with highly variable features, and typical signs of the syndrome may not be observed in all cases. This study expands the clinical spectrum of this rare syndrome and contributes to its genetic spectrum with the identification of new variants. • Coffin-Siris syndrome (CSS) is a clinically and genetically heterogeneous neurodevelopmental disorder most commonly caused by variants in SWI/SNF (BAF) complex genes (e.g., ARID1B, SMARCA4) and characterized by dysmorphic features, developmental delay, hypertrichosis, and fifth-digit/nail anomalies. • Endocrine and growth-related manifestations can occur in CSS, but their frequency and phenotypic range vary across cohorts and require individualized clinical follow-up. • This case series of eight genetically confirmed CSS patients (7 ARID1B, 1 SMARCA4) expands the phenotypic spectrum by detailing dysmorphic findings together with endocrine features including pathological short stature with delayed bone age, hypothyroidism, transient hypercalcemia, cryptorchidism, and recurrent fractures. • We identified eight pathogenic/likely pathogenic variants, including two novel variants, and highlight that fifth digit/nail involvement may be subtle (mild terminal fifth phalanx hypoplasia and minor fifth nail changes) rather than overt.

#5

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.

BMJ open2026 Feb 27

Down syndrome (DS) is a major cause of genetically defined intellectual disability, characterised by low IQ and cognitive deficits. Among the neurobiological causes of these deficits, disruptions in gamma-aminobutyric acid (GABA)ergic signalling in the hippocampus and an excitation/inhibition imbalance are thought to impair learning and memory. Evidence suggests that GABAA receptor-mediated signalling in DS is significantly depolarising and potentially excitatory rather than predominantly hyperpolarising and inhibitory, and is accompanied by increased hippocampal expression of the cation-chloride cotransporter NKCC1. The treatment with the NKCC1 inhibitor bumetanide restored GABAergic signals, synaptic plasticity, hippocampus-dependent memory and sleep quality in adult DS mice. We hypothesise that the use of bumetanide, by re-establishing GABAergic signals, may improve memory, learning and psychological characteristics in children and adolescents with DS. The present study is a randomised, double-blind, placebo-controlled trial to evaluate the efficacy of a 3-month treatment with the drug bumetanide (0.02 mg/kg two times per day or placebo) on memory and psychological functioning in children and adolescents with DS. We also aim to identify possible predictors and biological and genetic markers related to treatment.The target recruitment is 64 children and adolescents with DS (aged 10-17 years). Seven visits are scheduled for each participant, during which outcome and safety measures are assessed through various clinical and instrumental investigations.Outcome measures include neuropsychological and psychological assessments, as well as biomarkers. Neuropsychological measures consist of tests evaluating cognitive level, memory and executive functions. Psychological measures include parent-reported questionnaires on psychopathological and behavioural symptoms, quality of life, sleep and adaptive functioning. Biomarkers encompass electroencephalogram (EEG) and genomic, transcriptomic, proteomic and metabolomic evaluations from blood and urine samples.Safety measures include physical, nephrological, cardiological and audiometric evaluations, as well as blood and urine analysis, EEG, ECG and a pregnancy test (if applicable). Neuropsychological, psychological, biomarker and safety measures are collected at baseline (visit 1 (V1)), at the end of treatment (V6) and during follow-up (V7), which is scheduled for 2 months after the end of treatment. Interim psychological and safety assessments are conducted at 1 week (V2), 2 weeks (V3), 1 month (V4) and 2 months (V5) after the start of treatment. We expect bumetanide treatment to improve visual long-term memory skills (primary outcome). Additionally, we expect improvements in total scores and subdomain scores across other visual, verbal and spatial long-term memory tasks, as well as executive functions, psychopathological measures, adaptive functioning, sleep quality and quality of life scores (secondary outcomes). Furthermore, we expect potential differences in genomic, transcriptomic, proteomic and metabolomic profiles between patients who respond to therapy and those who do not. Ethical approval for this study was granted by the Bambino Gesù Children's Hospital Ethics Committee (process number 1042_OPBG_2016) and the Italian Medicines Agency. Substantial Amendment No 5 (ES5) was approved on 20 September 2023 by the Italian National Paediatric Ethics Committee and involved a revision and integration of the study protocol, now updated to version 8.1, in line with the recommendations of the Data Safety Monitoring Board.This study is being conducted in accordance with the Declaration of Helsinki. The present study protocol adheres to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines and was prepared using the SPIRIT 2025 Checklist. In accordance with Good Clinical Practice, written informed consent is obtained from all participants' parents or caregivers, and assent is obtained from participants when possible. The main features of the study will be presented at both international and national conferences, during scientific meetings, in presentations to families and on social media using documentation approved by competent authorities. The study was prospectively registered in the EudraCT portal on 16 August 2016, prior to the enrolment of the first participant on 11 January 2023 (https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005780-16/IT). In accordance with Regulation (EU) 536/2014 for pharmacological interventional trials, the study was subsequently transitioned to the Clinical Trials Information System (EU CT No 2024-519342-71-00), with the initial record entered on 23 December 2024, and the transition authorised on 3 February 2025 (https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-519342-71-00). EudraCT 2015-005780-16.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Etiological Diagnosis and Disease Course of Birk-Barel Syndrome in an Adult Woman with a KCNK9 Variant.

International medical case reports journal
2026

Reporting a Novel Disease Causing Variant in PGAP3 Associated With Hyperphosphatasia and Intellectual Disability: A Case Report and Comprehensive Literature Review.

Molecular genetics &amp; genomic medicine
2026

Combining blood biomarkers and the German version of the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID-G) for diagnosing cognitive decline in Down syndrome.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2026

The R203W substitution drives PACS-1 syndrome by disrupting intramolecular regulation.

The FEBS journal
2026

Case Report: Transient severe T cell lymphopenia in a patient with Cornelia de Lange Syndrome captured by TREC screening.

Frontiers in immunology
2026

A Novel MID1 Mutation Identified in a Patient With Craniofacial Anomalies and X-Linked Intellectual Disability.

The Journal of craniofacial surgery
2025

Clinical and molecular findings in Cornelia de Lange syndrome. Case series.

Andes pediatrica : revista Chilena de pediatria
2026

Biallelic SUPT4H1 Variants Cause a Multisystem Neurodevelopmental Disorder Associated with Disrupted Transcription.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Strengthening Undergraduate Medical Education for Inclusive Health Care for People With Down Syndrome and Intellectual and Developmental Disabilities in Medical Schools: Protocol for a Scoping Review.

JMIR research protocols
2026

A novel KDM6A c.2429dup mutation causing kabuki syndrome type 2 identified in a fetus with increased nuchal translucency.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

Multisystem manifestations of Sjögren-Larsson syndrome in early childhood and its dental implications.

BMJ case reports
2026

The Management of Evolving Neuropsychiatric Symptoms in a Female with Fragile X Syndrome: A Case Report.

Psychopharmacology bulletin
2026

Tuberous sclerosis complex.

Nature reviews. Disease primers
2025

[Clinical features and genetic etiology analysis in a patient with Fliedner-Zweier syndrome caused by a de novo SCAF4 variant].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Novel ANKRD11 Mutation in KBG Syndrome: A diagnostic triad of hearing loss, radiological macrodontia and artificial intelligence-assisted facial phenotyping.

Sultan Qaboos University medical journal
2026

De Novo 3q27.1 Microdeletion Refines the Critical Region and Implicates PSMD2 Haploinsufficiency in Growth and Neurodevelopmental Abnormalities.

American journal of medical genetics. Part A
2026

Development of an integrative cross-omics approach for conceptual adverse outcome pathway network construction.

Environment international
2026

Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.

European journal of pediatrics
2026

General Anesthesia for a Child With Sjögren-Larsson Syndrome.

Anesthesia progress
2026

Lamb-Shaffer syndrome in a Chinese adolescent: A case report.

Medicine
2026

Case Report: Identification of a de novo missense variant in the N-terminal zinc-finger domain of ZEB2 in a patient presenting with neurodevelopmental delay and recurrent pulmonary infections.

Frontiers in genetics
2026

Myhre Syndrome Presenting With Congenital Proximal Radioulnar Synostosis: A Case Report.

Cureus
2026

A novel variant in ARID2 causes Coffin-Siris syndrome 6 with liver cirrhosis.

Gene
2026

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.

BMJ open
2026

Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.

Human molecular genetics
2026

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences
2026

Reassessing Benign ASXL1 Variants in Bohring-Opitz Syndrome: The Role of Population Databases in Variant Reinterpretation.

Genes
2026

RNAi-Induced Expression of Paternal UBE3A.

Genes
2026

Foundations of an Ovine Model of Fragile X Syndrome.

Genes
2026

Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant.

Genes
2026

Orofacial clefting in PHF6-related Börjeson-Forssman-Lehmann syndrome.

BMJ case reports
2026

A Novel Association Between Mandibulofacial Dysostosis with Microcephaly and Congenital Diaphragmatic Hernia.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2026

Congenital core myopathy linked to SOX5: Expanding the phenotypical spectrum of Lamb-Shaffer syndrome.

Journal of neuromuscular diseases
2026

Prenatal Diagnosis and Genotype-Phenotype Correlation in 8q21.11 Microdeletion Syndrome: A Case Report.

International medical case reports journal
2026

Erythropoietin alleviates syndrome-associated intellectual disability and autism-like behavior in Zbtb20-haploinsufficient Primrose syndrome mouse model.

JCI insight
2026

Case Report: A female case of X-linked intellectual disability syndrome type 34 caused by a NONO frameshift variant and literature review.

Frontiers in pediatrics
2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics
2026

Cognitive Predictors of Adaptive Behaviour in Children With Down Syndrome: A Systematic Review.

Journal of applied research in intellectual disabilities : JARID
2026

Up-regulation of Minibrain/DYRK1A contributes to macrocephaly and brain overgrowth in a Drosophila model of fragile X syndrome.

Proceedings of the National Academy of Sciences of the United States of America
2026

A case of Kabuki syndrome with congenital pulmonary airway malformation.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research
2026

First Report of a Child With a DeSanto-Shinawi Syndrome and a Polymorphous Low-Grade Neuroepithelial Tumor of the Young.

American journal of medical genetics. Part A
2026

A novel CEP57 gene mutation in mosaic variegated aneuploidy syndrome 2: case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2026

Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2026

Börjeson-Forssman-Lehmann Syndrome in a Pediatric Patient: A Four-Year Longitudinal Case Report Focused on Functional Evolution and Rehabilitation.

Cureus
2026

Convergence and divergence of molecular phenotypes in iPSC-derived models of 16p11.2 and 22q11.2 reciprocal copy number variants.

Current opinion in genetics &amp; development
2026

Longitudinal Behavior Phenotype Hallmarks in RNU4-2 Syndrome: Implications for Clinical Management.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2026

CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder.

Journal of neurochemistry
2026

Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndrome.

Biochimica et biophysica acta. Molecular basis of disease
2026

Management of Pathological Dental Attrition in Prader-Willi Syndrome: A Case Report Using the Personalized Radboud Strategy.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2026

Dental rehabilitation under general anesthesia in an outpatient setting for a child with a heterozygous BCL11B variant: a case report.

BMC oral health
2026

Clinical and genetic characterization of patients with Digeorge syndrome: a single-center, first report from Sudan.

BMC pediatrics
2025

ASXL3 gene variants causing Bainbridge-Ropers syndrome: clinical and genetic analysis of four Chinese patients.

Frontiers in neuroscience
2026

Behavioral Phenotype Associations With Resting State EEG Signal Complexity and Power Spectral Density in Fragile X Syndrome.

Autism research : official journal of the International Society for Autism Research
2026

Hippocampal glial alterations are associated with Lamin B1 dysregulation and abnormal nuclear morphology in a rat model of fragile X syndrome.

Neurobiology of disease
2025

[Analysis of variants of VPS13B gene in a child with Cohen syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Analysis of a child with You-Hoover-Fong syndrome due to compound heterozygous variants of the TELO2 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Bi-allelic loss-of-function variants in JKAMP cause a neurodevelopmental syndrome associated with dysregulation of GPR37 trafficking.

American journal of human genetics
2026

Life expectancy of people with intellectual disability: a retrospective cohort study from New South Wales, Australia.

BMJ open
2026

Perioperative Management of a Pediatric Patient With Koolen-de Vries Syndrome Presenting for Posterior Spinal Fusion.

Journal of medical cases
2026

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus
2026

ReNU Syndrome due to a de novo RNU4-2 Variant as a Novel Genetic Cause of Proteinuria.

Kidney medicine
2026

A Patient With Intellectual Disability, Agenesis of Corpus Callosum, and Congenital Heart Disease Associated With Chromosome 10p11.2 Microdeletion.

American journal of medical genetics. Part A
2026

The Role of Pyridoxine Treatment for Seizures in Patients with PGAP3-Congenital Disorders of Glycosylation.

Annals of Indian Academy of Neurology
2026

Associations between receptive and expressive vocabulary and early literacy in young students with intellectual disabilities using AAC.

Research in developmental disabilities
2026

Bardet-Biedl syndrome presenting with early-onset infantile obesity.

BMJ case reports
2025

Simultaneous occurrence of bilateral retroperitoneal neuroblastoma and bifocal malignant mixed germ cell tumor in a pediatric patient with 16p11.2 microdeletion syndrome: a case report.

Frontiers in endocrinology
2026

miRNAs mediated Hsa21 gene suppression as potential therapeutic agent for Down syndrome: molecular dynamics and MM/PBSA-based study.

Journal of molecular modeling
2026

Beyond Neurodevelopmental Delay: BICRA-Related Coffin-Siris Syndrome 12 with Severe Intestinal Dysmotility and Recurrent Pneumothorax.

Genes
2026

Prenatal Diagnosis of a Feingold Syndrome Pregnancy Complicated with Severe Preeclampsia: A Report of a Challenging Case.

Genes
2026

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica
2025

New Insights into the Relation between Cognition, Behavior, and the CHD5 Gene: A Case-Report of an Adult Male with Parenti-Mignot Neurodevelopmental Syndrome.

Molecular syndromology
2026

Transcription factor ZEB2 is essential for ureteral smooth muscle cell differentiation.

PLoS genetics
2026

Prenatal Diagnosis of Radio-Tartaglia Syndrome Caused by a Loss-of-Function Variant in SPEN in a Chinese Family.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

Malformation Pattern and Molecular Findings in the FGFR1-Related Hartsfield Syndrome Phenotype.

Medical sciences (Basel, Switzerland)
2025

Intellectual Developmental Disorder of Autosomal Dominant 61 Caused by a MED13 Variant Presenting With Congenital Unilateral Sensorineural Hearing Loss: A Case Report.

Cureus
2026

Novel variants in STAG2 and PKD1 associate with multiple congenital malformations and autosomal dominant polycystic kidney disease in a Chinese family: A case report and literature review.

Experimental and therapeutic medicine
2026

Olfactory Deficits in Fragile X Syndrome.

The European journal of neuroscience
2026

Cochlear Implantation Via Extended Endaural Incision in a Patient With Congenital Ear Malformation.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2026

First Detection of 1p36 Deletion by Whole-Exome Sequencing in a Tunisian Patient.

Birth defects research
2025

Suboccipital Atretic Cephalocele as a Marker for Joubert-Plus Syndrome: An Extended Phenotype of the CPLANE1 Gene Mutation.

Cureus
2026

Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2026

MiR-874-3p suppresses TNF-α-induced inflammation in adipocytes by targeting nucleolin.

Journal of molecular histology
2026

Identification of novel variants in the ARID1B gene causing Coffin-Siris syndrome.

European journal of pediatrics
2026

Single-cell atlas of the developing Down syndrome brain cortex.

Nature medicine
2026

Proximal Junctional Kyphosis Following Spinal Thoracic Deformity Correction in a Patient with Kabuki Syndrome: A Case Report.

Journal of orthopaedic case reports
2026

Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.

Pediatric neurology
2026

Development of a patient-centered conceptual disease model in Ring 14 syndrome: a patient-centered model of lived experience.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
2026

Clinical and Genetic Analysis of SMARCC2-Related Diseases in Three Chinese Patients.

Molecular genetics &amp; genomic medicine
2026

Familial Presentation of a Rare NCKAP1 Splice-Site Variant Associated With a Neurodevelopmental Disorder and Cutaneous Manifestations.

American journal of medical genetics. Part A
2026

Alpha-mannosidosis due to a novel MAN2B1 truncating mutation in a Chinese patient: a new report and long-term follow-up.

Documenta ophthalmologica. Advances in ophthalmology
2026

A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers.

Clinica chimica acta; international journal of clinical chemistry
2026

The Italian Angelman Syndrome Registry (IReAS): a tool for standardized data collection and genotype-phenotype analysis.

European journal of medical genetics
2026

What Motivates Parents of Young Children With Down Syndrome to Participate in Research: A Focus Group Analysis.

Journal of applied research in intellectual disabilities : JARID
2026

Proceedings of the 12th International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

The missense mutation Y65C in PQBP1 causes microcephaly and cognitive deficits through a combination of partial loss-of-function and gain-of-function effects.

Nature communications
2026

Temporal transcriptomic changes during neurodevelopment in a mouse model of Smith-Lemli-Opitz syndrome.

The Journal of steroid biochemistry and molecular biology
2026

White-Sutton Syndrome: Insight of an Italian Cohort of 19 Subjects.

Clinical genetics
2026

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes.

The Journal of clinical psychiatry
2026

RO4938581, a GABAA-α5 negative allosteric modulator rescued behavioral and EEG phenotypes of a mouse model of Dup15q syndrome.

Molecular psychiatry
2026

The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β-Actin Impairs Its Cellular Polymerization and Stability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Case Report: An exploration of the neurodevelopmental phenotype of five patients with 48,XXYY during early childhood years.

Frontiers in endocrinology
2026

Pediatric floating-harbor syndrome: clinical features and treatment outcomes in a cohort of Chinese children.

European journal of pediatrics
2026

Therapeutic GSK-3β targeting stabilizes multifunctional β-catenin to rescue neuronal and behavioral deficits in fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research bulletin
2025

Joint hypermobility as a manifestation of neonatal Sotos syndrome.

BMJ case reports
2026

Clinical Insights Into a Rare SETD2 Disorder: Report of a Novel Variant.

Developmental neurobiology
2025

Clinical and Molecular Spectrum of PPP2R1A-Related Neurodevelopmental Disorders: A Systematic Review.

Genes
2025

Beyond the Diagnosis: A Journey of an 8-Year-Old Girl with Patau Syndrome: Case Report.

Children (Basel, Switzerland)
2026

Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation.

Circulation
2025

A Truncating Variant in the ERCC6 Gene With Three Different Phenotypes: Significant Effects of Modifier Genes.

Genetics research
2025

Improving variant interpretation and diagnosis in Koolen-de Vries syndrome through a curated genotype-phenotype repository.

Molecular genetics and genomics : MGG
2025

[Clinical and genetic analysis of a child with X-linked Hoyeraal-Hreidarsson syndrome due to variant of DKC1 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

A pediatric case of diphthamide biosynthesis 1 gene defect presenting with developmental delay, short stature, dysmorphic features, and sparse hair (Loucks-Innes syndrome): a case report.

Journal of medical case reports
2025

Transcriptomic signatures in brain and blood related to cognitive and psychiatric phenotypes of Prader-Willi syndrome.

Scientific reports
2026

Prevalence and Modifiable Risk Factors of Dementia in People With Down Syndrome: Cross-Sectional Study of Japan in Collaboration With the Intellectual Diversity for Goodness Research Consortium (INDIGO-2019).

Journal of intellectual disability research : JIDR
2026

Microstructural White Matter Alterations in Angelman Syndrome: A Fixel-Based Analysis.

Autism research : official journal of the International Society for Autism Research
2025

Significant improvement of neurological and radiological findings caused by multiple lateral meningocele by cyst-subarachnoid shunt in a 6-year-old boy: case report.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Clinical and neuropsychological characterization of Jacobsen syndrome (del11q).

Journal of neurodevelopmental disorders
2025

"Being brave, being seen, and having your voice heard": Perspectives of self-advocates and families toward accessible and impactful research of Alzheimer's disease in down syndrome.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

Novel KDM3B Variants in Two Chinese Patients With Global Developmental Delay and Autism.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2026

Altered Auditory Maturation in Fragile X Syndrome and Its Involvement in Audiogenic Seizure Susceptibility.

Autism research : official journal of the International Society for Autism Research
2025

Sexual Health and Transition Needs in an Adolescent Girl With Attention-deficit Hyperactivity Disorder and Smith-magenis Syndrome.

Journal of developmental and behavioral pediatrics : JDBP
2025

A new case of Rafiq syndrome with coexisting thyroid dyshormonogenesis type 6 in a Chinese patient: case report and literature review.

Frontiers in endocrinology
2026

Generation and characterization of a human-derived iPSC line (HZSMHCi003-A) from a male child with fragile X syndrome.

Stem cell research
2026

Functional evaluation of NAA10 variants in patients with Ogden syndrome.

Psychiatric genetics
2025

Comorbidity of Attention Deficit Hyperactivity Disorder (ADHD) and Chung-Jansen Syndrome: Case Report and Review of Literature.

Clinical case reports
2025

Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling.

Frontiers in endocrinology
2025

Revealing Monogenic Diabetes: Clinical and Genetic Features of Pediatric MODY Cases in Türkiye: Single Center Experience.

Pediatric diabetes
2025

Anesthetic Management of a Patient With Myhre Syndrome.

Anesthesia progress
2025

Ambulatory General Anesthesia for Dental Treatment in a Patient With Williams Syndrome and Supravalvular Aortic Restenosis: A Case Report.

Anesthesia progress
2026

Respiratory Involvement in HIST1H1E-Related Rahman Syndrome: A Case of Severe Mixed Apnea.

American journal of medical genetics. Part A
2025

Down Syndrome in British Maternity Care: Mothers' Experiences of Prenatal Testing and Receiving a Prenatal or Postnatal Diagnosis.

Journal of applied research in intellectual disabilities : JARID
2026

Shank3B-/- pathophysiology: Early metformin treatment rescues behavioural deficits and normalises exacerbated mRNA translation.

Neurobiology of disease
2025

Five novel EP300 variants expand the genetic and phenotypic spectrum of Rubinstein-Taybi syndrome type 2 in Chinese patients.

Frontiers in genetics
2026

Simpson-Golabi-Behmel Syndrome Associated With a Missense Variant at the Signal Peptide Cleavage Site of GPC3.

American journal of medical genetics. Part A
2025

Capsaicin camphor and caffeic acid reduce adipogenesis and promote lipolysis with TRPV1 involvement.

Scientific reports
2026

Vocabulary and Syntactic Development in Japanese Children With Autism Spectrum Disorder and Down Syndrome Accompanied by Intellectual Disability.

Journal of intellectual disability research : JIDR
2026

Modeling Mowat-Wilson syndrome with patient iPSCs reveals transcriptional and phenotypic defects in neural progenitors.

Neurobiology of disease
2026

Revisiting Wiedemann-Steiner Syndrome: Novel KMT2A Variants and Broadened Clinical Spectrum.

Balkan medical journal
2025

Delayed Diagnosis of 48XXYY Syndrome: A Case Report Highlighting the Role of G-Banding Cytogenetics.

Journal of UOEH
2025

Co-Occurrence of Urogenital Anomalies and Congenital Heart Disease in a Child With Alpha-Thalassemia Mental Retardation Syndrome Associated With Chromosome 16 Abnormalities due to Partial Monosomy 16p13.3 and Partial Trisomy 16q22.1-q24.3.

Congenital anomalies
2026

Preventing Differentiation Towards Primitive Macrophages in Stem Cells With Down Syndrome.

Immunology
2025

Prevalence of neurodevelopmental and psychiatric disorders in Noonan syndrome: a systematic review and meta-analysis.

European journal of pediatrics
2025

Kmt2c/Mll3 Haploinsufficiency Causes Autism-like Behavioral Deficits in Mice.

Biomolecules
2025

Prenatal Diagnosis of 6q Terminal Deletion Associated with Coffin-Siris Syndrome: Phenotypic Delineation and Review.

Genes
2025

A Novel STAG2 Frameshift Variant in Mullegama-Klein-Martinez Syndrome with Complex Conotruncal Heart Defect.

Genes
2025

Non-Classic Cornelia de Lange Syndrome Due to BRD4 Gene Alterations: A Literature Review.

Children (Basel, Switzerland)
2025

Effects of Metformin on children with Fragile X Syndrome: a randomized, double-blind, placebo-controlled trial.

Molecular autism
2025

Long-read sequencing identifies a novel de novo inversion in SMARCC2 in a pediatric patient with Coffin-siris syndrome 8: a case report.

BMC medical genomics
2026

Macular and optic nerve hypoplasia in chromosome 2p partial trisomy.

Ophthalmic genetics
2026

A Phenotype-Enhanced Variant Classification Framework to Decrease the Burden of Variants of Uncertain Significance in Type 2 Long QT Syndrome.

JACC. Clinical electrophysiology
2025

Case Report: Co-occurring de novo SHANK3 and SRCAP variants in a patient with autoimmune encephalitis and exhibiting Phelan-McDermid syndrome features.

Frontiers in genetics
2025

The Diagnostic Performance of Nuchal Translucency Alone as a Screening Test for Down Syndrome: A Systematic Review and Meta-analysis.

Acta medica Philippina
2025

Clinical variation in Lowe syndrome: what and how?

Frontiers in cell and developmental biology
2025

Proteome Signature of Alzheimer-Like Phenotypes in Frontal Cortices From Young and Old Individuals With Down Syndrome.

Molecular neurobiology
2026

Nutrition Practices Reported by Families of Children with Down Syndrome, Autism, and Without an Intellectual or Developmental Disability.

Journal of nutrition education and behavior
2026

9q34.11 Microduplications Encompassing SET Gene Are Associated With Neurodevelopmental Disorder and Recurrent Dysmorphisms.

American journal of medical genetics. Part A
2025

Unveiling the alterations of action processing and mu rhythm in Williams Syndrome.

NeuroImage
2025

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

Transcription factor 4 regulates the interhemispheric midline remodeling through neuron-astroglia communications during corpus callosum formation.

Translational psychiatry
2025

Cardiovascular Collapse During Scoliosis Surgery in a Patient With Coffin-Lowry Syndrome and Mesocardia.

Cureus
2025

Personalized Treatment in Rare Genetic Syndromes: A Case-Report in Witteveen-Kolk Syndrome (SIN3A).

Molecular syndromology
2026

Prominent U-waves without QT prolongation in X-linked creatine transporter deficiency caused by SLC6A8 variants.

Heart rhythm
2025

A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability.

Molecular biology reports
2025

A Novel De Novo KDM3B Variant in the Youngest Reported Male Patient With Diets-Jongmans Syndrome and Facial Asymmetry.

Clinical genetics
2026

Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes.

American journal of medical genetics. Part A
2025

[Clinical and genetic characteristics of 6 cases of congenital dyskeratosis in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Development of Molecular Neuropathology in Down Syndrome across the Lifespan.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2025

Dilated cardiomyopathy in Rubinstein-Taybi syndrome: A case report and mini-review of the literature.

Medicine international
2025

Childhood Neurocognitive Outcomes in Patients With Fontan Circulation.

Journal of the American Heart Association
2025

Two Chinese patients with Basilicata-Akhtar syndrome caused by novel MSL3 variants: a case report and literature review.

Translational pediatrics
2025

A frameshift variant in activity-dependent neuroprotective protein (ADNP) causes nucleocytoskeletal alterations in a dizygotic male twin: a case study.

Clinical epigenetics
2025

Are NONO variants linked to congenital heart disease? Patient reports and review.

European journal of medical genetics
2025

Gene Therapy for Fragile X Syndrome, Challenges, and Promises.

The journal of gene medicine
2025

MEHMO syndrome: Review and proposed classification as an eIF2-related neuroendocrinopathy.

Molecular genetics and metabolism
2025

Stressful life experiences and mental health symptoms in adults with down syndrome.

Research in developmental disabilities
2025

First Report of a Familiar MYCBP2 Pathogenic Variant: Expanding the Knowledge of Neurodevelopmental Disorders.

Balkan journal of medical genetics : BJMG
2025

Novel KIF11 Variants with New Clinical Features: Expanding the Clinical Phenotype.

Balkan journal of medical genetics : BJMG
2026

The Detection of Down Syndrome Arthritis in Clinical Practice: A Multicenter, International Pilot and Feasibility Study of a Down Syndrome-Specific Musculoskeletal Screening Tool.

American journal of medical genetics. Part A
2025

A novel frameshift variant in the MED13 gene causing intellectual developmental disorder-61 in a Chinese family.

Frontiers in pediatrics
2025

Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case.

BMC pediatrics
2025

First description of co-occurrence of 49,XXXXY and X-linked Cornelia de Lange syndrome: case report.

Frontiers in endocrinology
2025

Aberrant hippocampal gamma oscillations in a mouse model of fragile X syndrome: insights from in vitro slice models.

Molecular autism
2025

In-depth behavioral characterization of a rat model of Schaaf-Yang syndrome.

Scientific reports
2025

Optic nerve hypoplasia/dysplasia in Coffin-Siris syndrome: a case series.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Pre-Implantation factor (PIF) restores working memory and promotes microglial ramification in the adult Dp(16)1Yey mouse model of Down syndrome.

European journal of pharmacology
2026

Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis.

The Journal of molecular diagnostics : JMD
2025

Higher testosterone level is associated with improved cognitive functions in Klinefelter syndrome.

Andrology
2025

Personalized Follow Up and Genetic Diagnosis Update of FMR1-Related Conditions: A Change in Diagnosis, Prognosis and Expectations.

International journal of molecular sciences
2025

Expanding Clinical and Genetic Landscape of SATB2-Associated Syndrome.

Genes
2025

Rubinstein-Taybi Syndrome: A Comprehensive Analysis of a Polish Cohort with Most Cases Due to Novel CREBBP and EP300 Variants.

Genes
2025

Linking Genotype to Clinical Features in SMC1A-Related Phenotypes: From Cornelia de Lange Syndrome to Developmental and Epileptic Encephalopathy, a Comprehensive Review.

Genes
2025

Familial NSD1 Exon 3 Deletion Associated with Phenotypic and Epigenetic Variability.

Genes
2025

The p.Ile202Thr Substitution in TUBB2B Can Be Associated with Syndromic Presentation of Congenital Fibrosis of the Extraocular Muscles.

Genes
2025

Genetic and Molecular Insights into the Links Between Heat Stroke, Alzheimer's Disease, and Down Syndrome: A Mini-Review.

Genes
2025

Expanding the Clinical and Molecular Spectrum of Primary Autosomal Recessive Microcephaly: Novel CDK5RAP2 Gene Variants and Functional Insights on the Intronic Variants.

Genes
2025

Preserved phonological but impaired semantic processing in Williams syndrome: Evidence from a word association judgment task.

Research in developmental disabilities
2025

A Case Report: Co-Occurrence of TNRC6B Gene Variant and Xq28 Microdeletion Syndrome With Comprehensive Literature Review.

Birth defects research
2025

Modified Cued Recall Test for the Diagnosis of Alzheimer's Disease in a Greek Sample of Adults With Down Syndrome: A Preliminary Study.

American journal on intellectual and developmental disabilities
2026

Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.

Clinical genetics
2026

Adaptive mechanisms in pancreatic islets counteract mitochondrial dysfunction in Barth syndrome.

Diabetologia

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Biallelic SUPT4H1 Variants Cause a Multisystem Neurodevelopmental Disorder Associated with Disrupted Transcription.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41842694mais citado
  2. Multisystem manifestations of Sj&#xf6;gren-Larsson syndrome in early childhood and its dental implications.
    BMJ case reports· 2026· PMID 41825905mais citado
  3. Tuberous sclerosis complex.
    Nature reviews. Disease primers· 2026· PMID 41820375mais citado
  4. Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases.
    European journal of pediatrics· 2026· PMID 41795723mais citado
  5. Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.
    BMJ open· 2026· PMID 41760142mais citado
  6. Mast cell mediators in hereditary angioedema.
    Orphanet J Rare Dis· 2026· PMID 41832580recente
  7. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  8. Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis· 2026· PMID 41827036recente
  9. The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
    Orphanet J Rare Dis· 2026· PMID 41821052recente
  10. Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.
    Orphanet J Rare Dis· 2026· PMID 41821046recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:513456(Orphanet)
  2. OMIM OMIM:617616(OMIM)
  3. MONDO:0054636(MONDO)
  4. GARD:17953(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q104414279(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento intelectual-convulsões-marcha anômala-dismorfia facial

ORPHA:513456 · MONDO:0054636
Prevalência
<1 / 1 000 000
Casos
15 casos conhecidos
Herança
Autosomal dominant
CID-10
Q87.0 · Síndromes com malformações congênitas afetando predominantemente o aspecto da face
Início
Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4539927
Repurposing
21 candidatos
beclamideanticonvulsant
carbamazepinecarboxamide antiepileptic
eslicarbazepine-acetatesodium channel blocker
+17 outros
Wikidata
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades